Characteristics | High qSOFA n = 90 (%) | Low qSOFA n = 312 (%) | p value |
---|---|---|---|
Age, yr. a | 56.5 ± 13.99 | 55.2 ± 15.1 | 0.66 |
Male | 60 (67) | 241 (77) | 0.053 |
Residence Prior to Admission | |||
 Home | 66 (73) | 240 (77) | 0.81 |
 Skilled Nursing Facility | 5 (6) | 11 (4) |  |
 Other hospital/rehab center | 9 (10) | 30 (10) |  |
 Homeless | 10 (11) | 31 (10) |  |
Comorbid conditions | |||
 None | 2 (2) | 30 (10) | 0.02 |
 Diabetes Mellitus | 35 (39) | 142 (46) | 0.28 |
 End stage renal disease on dialysis | 16 (18) | 51 (16) | 0.75 |
 Cirrhosis | 11 (13) | 32 (11) | 0.52 |
 Cardiovascular disease b | 40 (44) | 170 (54) | 0.096 |
 Immunosuppressed c | 15 (17) | 37 (12) | 0.28 |
  ≥ 3 comorbid conditions | 45 (50) | 165 (53) | 0.63 |
Race/Ethnicity | Â | Â | 0.18 |
 Caucasian | 28 (33) | 92 (30) |  |
 Asian | 14 (16) | 26 (8) |  |
 African American | 10 (12) | 34 (11) |  |
 Hispanic | 32 (37) | 137 (44) |  |
 Other | 2 (2) | 21 (7) |  |
History of Intravenous Drug Use | 13 (15) | 32 (10) | 0.26 |
History of S. aureus infection | 14 (16) | 57 (18) | 0.08 |
History of IV vancomycin therapy | 12 (13%) | 45 (15%) | 0.79 |
Community-onset SAB | 77 (86) | 272 (87) | 0.72 |
Microbial characteristics | Â | Â | 0.03 |
 MSSA | 52 (58) | 219 (70) |  |
 MRSA | 38 (42) | 93 (30) |  |
Source Risk Category d | Â | Â | 0.0036 |
 Low risk | 20 (22) | 64 (21) |  |
 Intermediate risk | 43 (48) | 202 (65) |  |
 High risk | 26 (29) | 46 (15) |  |
Study site | Â | Â | 0.43 |
 County teaching hospital | 64 (71) | 205 (66) |  |
 Academic hospital | 11 (12) | 35 (11) |  |
 Community teaching hospital | 15 (17) | 72 (23) |  |